REVIEW article

Front. Immunol.

Sec. T Cell Biology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1591584

This article is part of the Research TopicThe Function and Regulation of T Cell Subsets in Inflammatory DiseaseView all 11 articles

Immunological pathogenesis of inflammatory bowel disease: focus on tissue resident memory T cells and their role

Provisionally accepted
Jiayan  HuJiayan Hu1Wenting  WangWenting Wang2Muyuan  WangMuyuan Wang1Chunye  WuChunye Wu3Yao  JiaoYao Jiao1Yitong  LiYitong Li1Wenji  ZhangWenji Zhang1Chengtao  LiangChengtao Liang1Zhengdao  LinZhengdao Lin1Yitong  YuYitong Yu1Junxiang  LiJunxiang Li1Tangyou  MaoTangyou Mao1*
  • 1Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China
  • 2Beitaipingzhuang Community Health Service Center, Beijing, P.R. China, Beijing, China
  • 3Beijing University of Chinese Medicine, Beijing, Beijing Municipality, China

The final, formatted version of the article will be published soon.

Tissue-resident memory T (TRM) cells are a type of tissue-restricted memory T cells with terminal differentiation and a memory function. They exist in mucosal tissues for a long period. In the absence of disease, TRM cells promote essential inflammation, which reinforces the intestinal barrier and prevents bacterial translocation. However, in inflammatory or autoimmune environments, TRM cells are hyperactivated. This heightened activity causes the host to release excessive pro-inflammatory cytokines, resulting in local immune imbalances and damage to the barrier, ultimately leading to tissue lesions. Numbers of studies have shown that TRM cells play a crucial role in the development and progression of inflammatory bowel disease (IBD), suggesting that targeted regulation of TRM cells homeostasis may be an important strategy for treating IBD. Here, we compiled the existing understanding of the role of TRM cells in IBD, with particular emphasis on the associated mechanisms and approaches for targeting TRM cells in IBD treatment. This review will serve as a foundation for a better understanding of IBD development and enhancing the effectiveness of clinical treatments for IBD.

Keywords: inflammatory bowel disease, tissue-resident memory T cells, Immune balance, mechanisms, strategies

Received: 11 Mar 2025; Accepted: 14 May 2025.

Copyright: © 2025 Hu, Wang, Wang, Wu, Jiao, Li, Zhang, Liang, Lin, Yu, Li and Mao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tangyou Mao, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.